OTCMKTS:GNGBY

Getinge Q4 2024 Earnings Results & Report

Getinge logo
$26.88 -0.39 (-1.44%)
As of 11/20/2026 03:58 PM Eastern

Getinge reported Q4 2024 earnings on January 28, 2025. The company reported EPS of $0.49.

Earnings Announcement Details

Quarter
Q4 2024
Report Date
Time
Before Market Opens

Getinge EPS Results

Actual EPS
$0.49
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Getinge Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

Getinge's next earnings date is estimated for Tuesday, January 26, 2027, based on past reporting schedules.

Conference Call Resources

Getinge Q4 2024 Earnings FAQ

Getinge (OTCMKTS:GNGBY) reported earnings of $0.49 per share for Q4 2024. The report was announced on Tuesday, January 28, 2025.

Getinge's next earnings date is estimated for Tuesday, January 26, 2027. MarketBeat tracks confirmed and estimated earnings dates for Getinge on the company's earnings history page.

Getinge Earnings Headlines

Getinge Establishes Sustainable Financing Framework
Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.tc pixel
Getinge AB Earnings Call Signals Steady Margin Climb
See More Getinge Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Getinge? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Getinge and other key companies, straight to your email.

About Getinge

Getinge (OTCMKTS:GNGBY) is a Swedish medical technology company that develops products and services for hospitals and life science organizations. Its offerings support patient care, surgical procedures, infection prevention and the production of medicines and other biological products.

The company’s portfolio includes equipment and solutions for intensive care, cardiovascular procedures and operating rooms, as well as sterilization and cleaning systems. Its life science business provides solutions used in areas such as pharmaceutical and biotechnology manufacturing.

Founded in 1904 in the Swedish town of Getinge, the company is headquartered in Gothenburg and serves customers in markets around the world. Mattias Perjos has served as Getinge’s president and chief executive officer since 2017.

View Getinge Profile